Medoflucon

Fluconazole, the active ingredient in Medoflucon, is an azole antifungal presented as an oral dosage form for oral use. It treats a range of Candida and Cryptococcus infections in adults and children as prescribed by a healthcare professional.

GNH USA supplies Medoflucon as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Fluconazole is an azole antifungal used to manage infections caused by susceptible fungi. - Vulvovaginal candidiasis: alleviates symptoms and eradicates Candida infection in the vaginal mucosa. - Oropharyngeal and esophageal candidiasis: clears fungal growth in the mouth and throat, improving swallowing and comfort. - Systemic candidiasis: treats bloodstream and deep‑tissue Candida infections, reducing mortality risk. - Cryptococcal meningitis: penetrates the central nervous system to control Cryptococcus neoformans infection. - Prevention of fungal infections in immunocompromised patients: provides prophylaxis during periods of high infection risk.

Fluconazole may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Nausea: mild stomach upset often occurring after the first dose. - Headache: transient headache reported by some patients. - Diarrhea: loose stools that usually resolve without intervention. - Abdominal pain: cramping or discomfort in the stomach area. - Rash: mild skin redness or itching. - Elevated liver enzymes: mild, reversible changes in liver function tests.

Serious or Rare Side Effects: - Hepatotoxicity: signs of liver injury such as jaundice or dark urine. - Severe skin reactions: Stevens‑Johnson syndrome or toxic epidermal necrolysis. - Cardiac arrhythmias: QT interval prolongation leading to irregular heartbeat. - Anaphylaxis: rare but life‑threatening allergic reaction. - Hematologic abnormalities: neutropenia or thrombocytopenia. - Visual disturbances: blurred vision or changes in color perception.

Before initiating therapy, clinicians should evaluate patient‑specific factors and monitor for potential complications. - Liver function assessment: check baseline hepatic enzymes and repeat if symptoms arise. - Renal function monitoring: adjust dosing in severe renal impairment as advised by prescriber. - Pregnancy considerations: discuss potential risks with a qualified obstetrician before use. - Drug‑interaction review: assess concomitant medications for known interactions. - Store at room temperature: keep in the original packaging, protect from moisture and direct sunlight.

Fluconazole can alter the plasma concentrations of several co‑administered drugs.

Major Interactions (Avoid): - Warfarin: increased anticoagulant effect may lead to bleeding. - Certain statins (e.g., simvastatin, lovastatin): risk of myopathy and rhabdomyolysis. - Phenytoin: reduced clearance may cause toxicity.

Moderate Interactions (Monitor Closely): - Oral hypoglycemics (e.g., glyburide): possible enhanced hypoglycaemic effect. - Benzodiazepines (e.g., midazolam): increased sedation; dose adjustment may be required.